Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
HCI Group
HCI
$2.41B
| $300K | ﹤0.01% |
6,480
+1,277
| +25% | +$55.3K |
|
3702
iRadimed
IRMD
$1.18B
| $299K | ﹤0.01% |
12,922
+8,553
| +196% | +$184K |
|
|
PCSB
3703
DELISTED
PCSB Financial Corporation
PCSB
| $299K | ﹤0.01% |
23,648
+18,475
| +357% | +$241K |
|
|
NVEE
3704
DELISTED
NV5 Global
NVEE
| $298K | ﹤0.01% |
23,376
-58,384
| -71% | -$657K |
|
3705
CALL
Sunrun
RUN
$2.46B
| $298K | ﹤0.01% |
+15,100
| New | +$231K |
|
3706
Capital City Bank Group
CCBG
$890M
| $297K | ﹤0.01% |
14,164
+4,441
| +46% | +$87.1K |
|
3707
PUT
NetApp
NTAP
$37.2B
| $297K | ﹤0.01% |
6,700
-86,900
| -93% | -$3.73M |
|
|
MCBC
3708
DELISTED
Macatawa Bank Corp
MCBC
| $297K | ﹤0.01% |
38,071
+29,437
| +341% | +$213K |
|
|
SJR
3709
DELISTED
Shaw Communications Inc.
SJR
| $297K | ﹤0.01% |
18,136
-5,893
| -25% | -$97.2K |
|
3710
Alerus Financial
ALRS
$828M
| $296K | ﹤0.01% |
14,948
+7,558
| +102% | +$136K |
|
3711
A10 Networks
ATEN
$1.93B
| $296K | ﹤0.01% |
43,568
+27,040
| +164% | +$182K |
|
3712
CALL
Teradyne
TER
$59.3B
| $296K | ﹤0.01% |
3,500
-7,600
| -68% | -$509K |
|
3713
CALL
Weibo
WB
$1.95B
| $296K | ﹤0.01% |
8,800
-13,500
| -61% | -$463K |
|
|
CTXS
3714
PUT
DELISTED
Citrix Systems Inc
CTXS
| $296K | ﹤0.01% |
2,000
-1,800
| -47% | -$259K |
|
3715
CALL
Abercrombie & Fitch
ANF
$5B
| $295K | ﹤0.01% |
27,700
-122,400
| -82% | -$1.34M |
|
3716
Crinetics Pharmaceuticals
CRNX
$8.92B
| $295K | ﹤0.01% |
16,788
+13,128
| +359% | +$224K |
|
|
RC
3717
Ready Capital
RC
$308M
| $295K | ﹤0.01% |
33,888
+1,603
| +5% | +$10.9K |
|
3718
Prothena Corp
PRTA
$459M
| $294K | ﹤0.01% |
28,166
-9,282
| -25% | -$103K |
|
3719
Metallus
MTUS
$898M
| $294K | ﹤0.01% |
75,539
+6,004
| +9% | +$20.1K |
|
|
DNR
3720
DELISTED
Denbury Resources, Inc.
DNR
| $294K | ﹤0.01% |
1,063,024
+562,078
| +112% | +$169K |
|
3721
Beazer Homes USA
BZH
$907M
| $293K | ﹤0.01% |
29,103
+10,675
| +58% | +$85.3K |
|
3722
QCR Holdings
QCRH
$1.7B
| $293K | ﹤0.01% |
9,375
+4,461
| +91% | +$129K |
|
3723
PUT
Sempra
SRE
$54.8B
| $293K | ﹤0.01% |
5,000
-1,000
| -17% | -$61.4K |
|
3724
BOK Financial
BOKF
$8.74B
| $292K | ﹤0.01% |
5,168
-13,729
| -73% | -$703K |
|
3725
Clearfield
CLFD
$374M
| $292K | ﹤0.01% |
20,967
+17,277
| +468% | +$224K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.